Tofacitinib reduced death or respiratory failure at 28 d in patients hospitalized with COVID-19 pneumonia
- PMID: 34606317
- DOI: 10.7326/ACPJ202110190-111
Tofacitinib reduced death or respiratory failure at 28 d in patients hospitalized with COVID-19 pneumonia
Abstract
Guimarães PO, Quirk D, Furtado RH, et al. Tofacitinib in patients hospitalized with Covid-19 pneumonia. N Engl J Med. 2021;385:406-15. 34133856.
Comment on
-
Tofacitinib in Patients Hospitalized with Covid-19 Pneumonia.N Engl J Med. 2021 Jul 29;385(5):406-415. doi: 10.1056/NEJMoa2101643. Epub 2021 Jun 16. N Engl J Med. 2021. PMID: 34133856 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical